CN Stock MarketDetailed Quotes

300003 Lepu Medical Technology

Watchlist
  • 12.02
  • -0.03-0.25%
Market Closed Dec 16 15:00 CST
22.60BMarket Cap31.97P/E (TTM)

Lepu Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-31.27%3.34B
-25.85%3.61B
-22.04%4.13B
-22.80%4.22B
-10.19%4.86B
39.38%4.87B
43.94%5.3B
43.97%5.47B
56.25%5.41B
-19.42%3.49B
Transactional financial assets
53.38%412.36M
63.62%439.44M
5.65%269.24M
-0.73%275.2M
--268.86M
766.38%268.58M
2,448.41%254.84M
--277.21M
----
7,858.34%31M
Notes receivable and accounts receivable
9.93%2B
26.57%2.17B
15.53%2.22B
-8.44%1.84B
2.16%1.82B
-6.57%1.71B
3.24%1.92B
17.03%2.01B
-15.38%1.78B
-17.00%1.83B
-Notes receivable
45.54%102.46M
11.43%93.02M
-2.26%93.22M
-14.09%84.51M
-44.97%70.4M
15.91%83.48M
286.85%95.38M
82.94%98.37M
807.88%127.93M
496.26%72.02M
-Accounts receivable
8.50%1.9B
27.34%2.07B
16.45%2.13B
-8.15%1.75B
5.80%1.75B
-7.49%1.63B
-0.56%1.83B
14.90%1.91B
-20.92%1.65B
-19.82%1.76B
Other receivables (including interest and dividends)
-11.17%142.67M
2.43%155.67M
-12.14%141.27M
-11.39%110.45M
-24.30%160.62M
-38.99%151.98M
-27.03%160.78M
-30.08%124.65M
-16.47%212.17M
18.49%249.1M
-Other receivable
----
2.43%155.67M
----
----
----
-38.99%151.98M
----
-30.08%124.65M
----
18.49%249.1M
Advance payment
-35.75%301.14M
-22.35%317.76M
-24.94%336.79M
-16.01%320.47M
18.64%468.73M
-0.99%409.25M
-8.71%448.69M
34.77%381.57M
15.92%395.08M
11.15%413.33M
Inventories
-9.81%2.22B
-7.66%2.27B
-8.25%2.22B
1.01%2.29B
9.74%2.46B
5.19%2.45B
16.06%2.42B
16.90%2.27B
15.89%2.24B
22.95%2.33B
Receivable financing
26.34%107.98M
-39.69%54.17M
-39.19%63.43M
-37.89%83.41M
-14.96%85.47M
11.42%89.81M
46.59%104.32M
65.75%134.29M
29.95%100.51M
-10.45%80.61M
Non-current assets due within one year
-35.06%2.24M
-3.54%3.64M
-27.81%3.07M
-31.84%3.3M
-45.10%3.44M
-40.18%3.77M
-43.02%4.26M
-84.79%4.84M
-82.44%6.27M
-84.68%6.3M
Other current assets
48.95%207.61M
49.10%199.95M
106.22%227.64M
115.98%184.7M
45.67%139.38M
9.20%134.1M
-15.04%110.39M
-29.71%85.52M
1.48%95.69M
39.88%122.81M
Total current assets
-14.93%8.73B
-8.70%9.21B
-10.35%9.61B
-13.24%9.33B
0.21%10.27B
17.88%10.09B
25.30%10.72B
31.93%10.75B
23.30%10.24B
-7.36%8.56B
Non Current assets
Other equity investment
-1.79%1.1B
-9.73%1.07B
-1.41%1.2B
1.82%1.19B
-7.02%1.12B
-2.89%1.18B
-11.53%1.21B
-22.57%1.17B
-20.78%1.21B
-34.34%1.22B
Other non-current financial assets
-4.74%26.5M
-84.74%26.5M
-83.92%26.5M
-83.29%26.5M
-79.24%27.82M
20.90%173.68M
85.43%164.77M
69.02%158.61M
-75.37%133.98M
-82.44%143.66M
Investment real estate
44.07%440.04M
25.76%387.51M
-5.20%295.17M
-10.14%296.77M
1.70%305.44M
1.56%308.14M
0.34%311.37M
3.98%330.25M
0.49%300.32M
0.49%303.4M
Long-term equity investment
-5.86%1.2B
4.61%1.26B
2.16%1.24B
10.11%1.35B
4.33%1.28B
-1.41%1.2B
-2.25%1.21B
14.72%1.23B
16.07%1.22B
52.11%1.22B
Long term receivable account
-78.83%935.79K
-85.77%789.85K
-64.92%2.82M
-64.06%2.97M
-49.75%4.42M
-46.16%5.55M
-25.05%8.05M
-25.78%8.26M
-50.13%8.8M
-42.34%10.31M
Fixed assets
----
56.67%4.12B
----
----
----
10.89%2.63B
----
19.35%2.6B
----
12.02%2.37B
Constru in process
----
-70.70%487.66M
----
----
----
22.51%1.66B
----
30.66%1.51B
----
60.84%1.36B
Intangible assets
21.31%1.7B
22.29%1.69B
27.56%1.76B
32.70%1.82B
1.38%1.4B
0.37%1.38B
-0.18%1.38B
-2.07%1.37B
-3.28%1.38B
0.07%1.38B
Development expenditure
-15.39%1.01B
-11.56%985.04M
-13.25%907.25M
-12.81%861.75M
35.02%1.19B
36.32%1.11B
38.02%1.05B
38.91%988.32M
47.69%882.63M
46.22%817.03M
Goodwill
8.52%3.84B
11.90%3.75B
12.65%3.75B
5.20%3.5B
6.41%3.54B
0.80%3.35B
0.63%3.33B
1.76%3.33B
11.98%3.33B
20.03%3.33B
Long deferred expense
25.94%310.65M
25.84%287.07M
25.02%279.57M
10.26%256.77M
5.46%246.67M
7.94%228.12M
14.38%223.61M
17.75%232.88M
25.21%233.9M
17.80%211.33M
Deferred tax assets
-1.43%166.67M
35.35%191.48M
23.78%160.28M
26.39%167.32M
16.39%169.08M
-0.61%141.47M
-7.54%129.49M
-3.76%132.39M
-10.08%145.28M
-11.46%142.34M
Usufruct assets
13.17%362.96M
10.87%378.19M
95.45%355.12M
47.10%326.43M
45.77%320.72M
42.52%341.12M
-3.87%181.69M
17.22%221.92M
99.22%220.02M
128.02%239.35M
Other non current assets
121.55%1.52B
133.82%1.45B
209.88%1.31B
187.42%1.28B
83.36%687.14M
49.21%618.34M
17.77%422.6M
49.52%446.13M
-4.70%374.75M
33.03%414.42M
Total non current assets
10.39%16.27B
12.09%16.08B
14.88%15.9B
14.28%15.7B
10.66%14.74B
9.06%14.35B
7.82%13.84B
9.44%13.74B
7.13%13.32B
7.66%13.16B
Total assets
-0.01%25.01B
3.51%25.3B
3.86%25.51B
2.19%25.02B
6.12%25.01B
12.54%24.44B
14.81%24.56B
18.29%24.48B
13.60%23.57B
1.19%21.72B
Liabilities
Current liabilities
Short term loan
-67.10%354.37M
29.11%1.13B
276.13%1.17B
173.07%1.04B
54.61%1.08B
41.86%875.32M
-51.76%311.68M
-34.79%380.77M
-39.42%696.72M
-49.87%617.03M
Transactional financial liabilities
----
----
----
----
----
----
--1.5M
----
----
----
Notes payable and accounts payable
-43.39%620.86M
-35.49%703.41M
-32.27%903.34M
-32.29%1.03B
-18.57%1.1B
-32.75%1.09B
-10.93%1.33B
11.52%1.52B
11.74%1.35B
22.55%1.62B
-Notes payable
-39.93%95.44M
-27.67%88.45M
-7.06%129.36M
-8.03%167.92M
5.71%158.9M
-5.32%122.28M
-33.97%139.18M
-20.11%182.57M
-17.69%150.32M
-5.89%129.15M
-Accounts payable
-43.97%525.42M
-36.48%614.96M
-35.21%773.98M
-35.61%861.37M
-21.62%937.8M
-35.13%968.18M
-7.16%1.19B
17.89%1.34B
17.00%1.2B
25.84%1.49B
Contract liabilities
-10.03%237.51M
-20.00%228M
-20.97%252.96M
-63.14%269.52M
-16.53%263.98M
-21.05%285.01M
-35.19%320.08M
106.55%731.12M
8.06%316.25M
-30.05%361M
Salaries payable
6.45%62.3M
-0.30%59.49M
-5.77%58.22M
-49.29%104.82M
-14.73%58.52M
-18.72%59.68M
-19.93%61.79M
3.58%206.7M
2.32%68.63M
16.53%73.42M
Taxs payable
-52.17%113.18M
-10.64%119.06M
6.43%273.13M
-40.15%199.11M
-30.07%236.62M
-50.65%133.24M
-4.34%256.61M
57.85%332.69M
91.53%338.36M
-13.34%269.98M
Other payable (including interest and dividends)
-4.18%463.55M
11.64%499.15M
22.19%521.77M
15.30%555.68M
24.98%483.77M
2.12%447.12M
21.10%427.01M
47.20%481.94M
42.62%387.09M
41.00%437.85M
-Dividend payable
548.68%21.75M
274.06%30.13M
0.00%3.35M
0.00%3.35M
42.34%3.35M
241.87%8.05M
--3.35M
-21.90%3.35M
0.00%2.36M
-92.01%2.36M
-Other payable
----
6.82%469.02M
----
----
----
0.82%439.07M
----
48.12%478.58M
----
54.95%435.49M
Non current liabilities due within one year
38.76%710.37M
-49.09%551.12M
-71.21%426.36M
-68.08%498.04M
79.54%511.93M
373.02%1.08B
678.70%1.48B
524.68%1.56B
45.34%285.13M
-20.40%228.85M
Other current liabilities
44.62%65.54M
0.61%67.19M
-20.08%61.84M
-43.12%62.47M
-5.92%45.32M
36.58%66.78M
65.82%77.37M
150.54%109.82M
112.55%48.17M
68.77%48.89M
Total current liabilities
-30.37%2.63B
-16.89%3.36B
-14.07%3.67B
-29.39%3.76B
8.23%3.77B
10.43%4.04B
19.55%4.27B
59.75%5.32B
3.11%3.49B
-10.14%3.66B
Current liabilities
Long term loan
98.61%2.86B
93.53%2.29B
38.89%1.62B
110.81%1.54B
23.44%1.44B
-6.24%1.18B
-4.31%1.17B
-39.52%731.55M
14.43%1.17B
4.77%1.26B
Bonds payable
2.53%1.59B
3.06%1.58B
3.08%1.56B
3.60%1.56B
-42.53%1.55B
-43.38%1.53B
-43.88%1.51B
-43.65%1.51B
3.12%2.7B
3.15%2.7B
Deferred tax liabilities
6.88%186.83M
-3.77%189.27M
-5.29%200.61M
-3.55%197.93M
-19.49%174.8M
-13.49%196.69M
-10.37%211.81M
-22.49%205.22M
-31.08%217.12M
-36.54%227.36M
Long term deferred income
-21.51%148.41M
-19.63%149.51M
-15.26%152.91M
6.24%195.22M
8.31%189.09M
24.63%186.03M
28.14%180.44M
31.22%183.75M
24.72%174.59M
6.21%149.27M
Lease liabilities
4.71%288.73M
5.83%292.09M
119.99%293.16M
65.90%269.97M
71.79%275.74M
54.24%276M
-0.58%133.26M
30.06%162.73M
133.83%160.51M
207.98%178.94M
Other non current liabilities
----
----
----
----
----
----
----
----
11.43%761.97M
6.47%720.86M
Total non current liabilities
39.74%5.08B
33.40%4.5B
19.40%3.83B
35.00%3.77B
-29.91%3.63B
-35.65%3.37B
-37.26%3.21B
-45.22%2.79B
6.88%5.18B
3.55%5.24B
Total liabilities
4.02%7.7B
5.99%7.86B
0.28%7.5B
-7.25%7.52B
-14.57%7.41B
-16.71%7.41B
-13.89%7.48B
-3.70%8.11B
5.33%8.67B
-2.56%8.9B
Shareholders equity
Paid-in capital
0.00%1.88B
0.00%1.88B
0.00%1.88B
0.00%1.88B
-0.66%1.88B
4.21%1.88B
4.21%1.88B
4.21%1.88B
4.90%1.89B
0.00%1.8B
Other equity instruments
-0.00%214.75M
-0.00%214.75M
-0.00%214.75M
-0.00%214.75M
-0.00%214.75M
-0.00%214.75M
-0.00%214.75M
-0.01%214.75M
-10.73%214.75M
-10.73%214.76M
Capital reserve funds
1.50%3.53B
2.70%3.52B
5.49%3.46B
6.83%3.46B
36.23%3.48B
210.12%3.43B
201.09%3.28B
229.68%3.24B
157.33%2.55B
12.34%1.1B
Surplus reserve funds
10.31%732.54M
10.31%732.54M
10.31%732.54M
10.32%732.54M
13.48%664.05M
13.48%664.05M
13.48%664.05M
13.48%664.04M
45.37%585.17M
45.37%585.17M
Retained profit
-2.28%10.14B
3.40%10.28B
4.81%10.68B
6.30%10.2B
9.91%10.38B
11.64%9.94B
17.50%10.19B
18.11%9.59B
11.90%9.44B
8.12%8.91B
Less:Treasury stock
71.01%608.49M
56.24%555.92M
42.14%505.77M
21.15%431.06M
-41.68%355.82M
-40.68%355.82M
-24.09%355.82M
-2.30%355.82M
139.93%610.1M
135.89%599.84M
Other composite income
-13.58%-92.23M
-251.53%-181.25M
-70.77%-83.67M
10.88%-80.89M
6.01%-81.2M
52.95%-51.56M
-6,951.87%-48.99M
-170.41%-90.76M
-169.84%-86.39M
-155.54%-109.59M
Shareholders equity without minority interests
-2.35%15.8B
1.08%15.89B
3.50%16.38B
5.47%15.98B
15.63%16.18B
32.04%15.72B
33.02%15.82B
32.01%15.15B
19.10%13.99B
2.53%11.91B
Minority interests
5.68%1.5B
18.64%1.55B
29.66%1.63B
24.24%1.52B
57.29%1.42B
43.28%1.31B
54.99%1.26B
53.14%1.22B
18.31%904.77M
27.19%911.57M
Total shareholder equity
-1.70%17.3B
2.43%17.44B
5.43%18.01B
6.88%17.5B
18.16%17.6B
32.84%17.03B
34.43%17.08B
33.39%16.37B
19.05%14.9B
3.97%12.82B
Total liabilityies and equity
-0.01%25.01B
3.51%25.3B
3.86%25.51B
2.19%25.02B
6.12%25.01B
12.54%24.44B
14.81%24.56B
18.29%24.48B
13.60%23.57B
1.19%21.72B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -31.27%3.34B-25.85%3.61B-22.04%4.13B-22.80%4.22B-10.19%4.86B39.38%4.87B43.94%5.3B43.97%5.47B56.25%5.41B-19.42%3.49B
Transactional financial assets 53.38%412.36M63.62%439.44M5.65%269.24M-0.73%275.2M--268.86M766.38%268.58M2,448.41%254.84M--277.21M----7,858.34%31M
Notes receivable and accounts receivable 9.93%2B26.57%2.17B15.53%2.22B-8.44%1.84B2.16%1.82B-6.57%1.71B3.24%1.92B17.03%2.01B-15.38%1.78B-17.00%1.83B
-Notes receivable 45.54%102.46M11.43%93.02M-2.26%93.22M-14.09%84.51M-44.97%70.4M15.91%83.48M286.85%95.38M82.94%98.37M807.88%127.93M496.26%72.02M
-Accounts receivable 8.50%1.9B27.34%2.07B16.45%2.13B-8.15%1.75B5.80%1.75B-7.49%1.63B-0.56%1.83B14.90%1.91B-20.92%1.65B-19.82%1.76B
Other receivables (including interest and dividends) -11.17%142.67M2.43%155.67M-12.14%141.27M-11.39%110.45M-24.30%160.62M-38.99%151.98M-27.03%160.78M-30.08%124.65M-16.47%212.17M18.49%249.1M
-Other receivable ----2.43%155.67M-------------38.99%151.98M-----30.08%124.65M----18.49%249.1M
Advance payment -35.75%301.14M-22.35%317.76M-24.94%336.79M-16.01%320.47M18.64%468.73M-0.99%409.25M-8.71%448.69M34.77%381.57M15.92%395.08M11.15%413.33M
Inventories -9.81%2.22B-7.66%2.27B-8.25%2.22B1.01%2.29B9.74%2.46B5.19%2.45B16.06%2.42B16.90%2.27B15.89%2.24B22.95%2.33B
Receivable financing 26.34%107.98M-39.69%54.17M-39.19%63.43M-37.89%83.41M-14.96%85.47M11.42%89.81M46.59%104.32M65.75%134.29M29.95%100.51M-10.45%80.61M
Non-current assets due within one year -35.06%2.24M-3.54%3.64M-27.81%3.07M-31.84%3.3M-45.10%3.44M-40.18%3.77M-43.02%4.26M-84.79%4.84M-82.44%6.27M-84.68%6.3M
Other current assets 48.95%207.61M49.10%199.95M106.22%227.64M115.98%184.7M45.67%139.38M9.20%134.1M-15.04%110.39M-29.71%85.52M1.48%95.69M39.88%122.81M
Total current assets -14.93%8.73B-8.70%9.21B-10.35%9.61B-13.24%9.33B0.21%10.27B17.88%10.09B25.30%10.72B31.93%10.75B23.30%10.24B-7.36%8.56B
Non Current assets
Other equity investment -1.79%1.1B-9.73%1.07B-1.41%1.2B1.82%1.19B-7.02%1.12B-2.89%1.18B-11.53%1.21B-22.57%1.17B-20.78%1.21B-34.34%1.22B
Other non-current financial assets -4.74%26.5M-84.74%26.5M-83.92%26.5M-83.29%26.5M-79.24%27.82M20.90%173.68M85.43%164.77M69.02%158.61M-75.37%133.98M-82.44%143.66M
Investment real estate 44.07%440.04M25.76%387.51M-5.20%295.17M-10.14%296.77M1.70%305.44M1.56%308.14M0.34%311.37M3.98%330.25M0.49%300.32M0.49%303.4M
Long-term equity investment -5.86%1.2B4.61%1.26B2.16%1.24B10.11%1.35B4.33%1.28B-1.41%1.2B-2.25%1.21B14.72%1.23B16.07%1.22B52.11%1.22B
Long term receivable account -78.83%935.79K-85.77%789.85K-64.92%2.82M-64.06%2.97M-49.75%4.42M-46.16%5.55M-25.05%8.05M-25.78%8.26M-50.13%8.8M-42.34%10.31M
Fixed assets ----56.67%4.12B------------10.89%2.63B----19.35%2.6B----12.02%2.37B
Constru in process -----70.70%487.66M------------22.51%1.66B----30.66%1.51B----60.84%1.36B
Intangible assets 21.31%1.7B22.29%1.69B27.56%1.76B32.70%1.82B1.38%1.4B0.37%1.38B-0.18%1.38B-2.07%1.37B-3.28%1.38B0.07%1.38B
Development expenditure -15.39%1.01B-11.56%985.04M-13.25%907.25M-12.81%861.75M35.02%1.19B36.32%1.11B38.02%1.05B38.91%988.32M47.69%882.63M46.22%817.03M
Goodwill 8.52%3.84B11.90%3.75B12.65%3.75B5.20%3.5B6.41%3.54B0.80%3.35B0.63%3.33B1.76%3.33B11.98%3.33B20.03%3.33B
Long deferred expense 25.94%310.65M25.84%287.07M25.02%279.57M10.26%256.77M5.46%246.67M7.94%228.12M14.38%223.61M17.75%232.88M25.21%233.9M17.80%211.33M
Deferred tax assets -1.43%166.67M35.35%191.48M23.78%160.28M26.39%167.32M16.39%169.08M-0.61%141.47M-7.54%129.49M-3.76%132.39M-10.08%145.28M-11.46%142.34M
Usufruct assets 13.17%362.96M10.87%378.19M95.45%355.12M47.10%326.43M45.77%320.72M42.52%341.12M-3.87%181.69M17.22%221.92M99.22%220.02M128.02%239.35M
Other non current assets 121.55%1.52B133.82%1.45B209.88%1.31B187.42%1.28B83.36%687.14M49.21%618.34M17.77%422.6M49.52%446.13M-4.70%374.75M33.03%414.42M
Total non current assets 10.39%16.27B12.09%16.08B14.88%15.9B14.28%15.7B10.66%14.74B9.06%14.35B7.82%13.84B9.44%13.74B7.13%13.32B7.66%13.16B
Total assets -0.01%25.01B3.51%25.3B3.86%25.51B2.19%25.02B6.12%25.01B12.54%24.44B14.81%24.56B18.29%24.48B13.60%23.57B1.19%21.72B
Liabilities
Current liabilities
Short term loan -67.10%354.37M29.11%1.13B276.13%1.17B173.07%1.04B54.61%1.08B41.86%875.32M-51.76%311.68M-34.79%380.77M-39.42%696.72M-49.87%617.03M
Transactional financial liabilities --------------------------1.5M------------
Notes payable and accounts payable -43.39%620.86M-35.49%703.41M-32.27%903.34M-32.29%1.03B-18.57%1.1B-32.75%1.09B-10.93%1.33B11.52%1.52B11.74%1.35B22.55%1.62B
-Notes payable -39.93%95.44M-27.67%88.45M-7.06%129.36M-8.03%167.92M5.71%158.9M-5.32%122.28M-33.97%139.18M-20.11%182.57M-17.69%150.32M-5.89%129.15M
-Accounts payable -43.97%525.42M-36.48%614.96M-35.21%773.98M-35.61%861.37M-21.62%937.8M-35.13%968.18M-7.16%1.19B17.89%1.34B17.00%1.2B25.84%1.49B
Contract liabilities -10.03%237.51M-20.00%228M-20.97%252.96M-63.14%269.52M-16.53%263.98M-21.05%285.01M-35.19%320.08M106.55%731.12M8.06%316.25M-30.05%361M
Salaries payable 6.45%62.3M-0.30%59.49M-5.77%58.22M-49.29%104.82M-14.73%58.52M-18.72%59.68M-19.93%61.79M3.58%206.7M2.32%68.63M16.53%73.42M
Taxs payable -52.17%113.18M-10.64%119.06M6.43%273.13M-40.15%199.11M-30.07%236.62M-50.65%133.24M-4.34%256.61M57.85%332.69M91.53%338.36M-13.34%269.98M
Other payable (including interest and dividends) -4.18%463.55M11.64%499.15M22.19%521.77M15.30%555.68M24.98%483.77M2.12%447.12M21.10%427.01M47.20%481.94M42.62%387.09M41.00%437.85M
-Dividend payable 548.68%21.75M274.06%30.13M0.00%3.35M0.00%3.35M42.34%3.35M241.87%8.05M--3.35M-21.90%3.35M0.00%2.36M-92.01%2.36M
-Other payable ----6.82%469.02M------------0.82%439.07M----48.12%478.58M----54.95%435.49M
Non current liabilities due within one year 38.76%710.37M-49.09%551.12M-71.21%426.36M-68.08%498.04M79.54%511.93M373.02%1.08B678.70%1.48B524.68%1.56B45.34%285.13M-20.40%228.85M
Other current liabilities 44.62%65.54M0.61%67.19M-20.08%61.84M-43.12%62.47M-5.92%45.32M36.58%66.78M65.82%77.37M150.54%109.82M112.55%48.17M68.77%48.89M
Total current liabilities -30.37%2.63B-16.89%3.36B-14.07%3.67B-29.39%3.76B8.23%3.77B10.43%4.04B19.55%4.27B59.75%5.32B3.11%3.49B-10.14%3.66B
Current liabilities
Long term loan 98.61%2.86B93.53%2.29B38.89%1.62B110.81%1.54B23.44%1.44B-6.24%1.18B-4.31%1.17B-39.52%731.55M14.43%1.17B4.77%1.26B
Bonds payable 2.53%1.59B3.06%1.58B3.08%1.56B3.60%1.56B-42.53%1.55B-43.38%1.53B-43.88%1.51B-43.65%1.51B3.12%2.7B3.15%2.7B
Deferred tax liabilities 6.88%186.83M-3.77%189.27M-5.29%200.61M-3.55%197.93M-19.49%174.8M-13.49%196.69M-10.37%211.81M-22.49%205.22M-31.08%217.12M-36.54%227.36M
Long term deferred income -21.51%148.41M-19.63%149.51M-15.26%152.91M6.24%195.22M8.31%189.09M24.63%186.03M28.14%180.44M31.22%183.75M24.72%174.59M6.21%149.27M
Lease liabilities 4.71%288.73M5.83%292.09M119.99%293.16M65.90%269.97M71.79%275.74M54.24%276M-0.58%133.26M30.06%162.73M133.83%160.51M207.98%178.94M
Other non current liabilities --------------------------------11.43%761.97M6.47%720.86M
Total non current liabilities 39.74%5.08B33.40%4.5B19.40%3.83B35.00%3.77B-29.91%3.63B-35.65%3.37B-37.26%3.21B-45.22%2.79B6.88%5.18B3.55%5.24B
Total liabilities 4.02%7.7B5.99%7.86B0.28%7.5B-7.25%7.52B-14.57%7.41B-16.71%7.41B-13.89%7.48B-3.70%8.11B5.33%8.67B-2.56%8.9B
Shareholders equity
Paid-in capital 0.00%1.88B0.00%1.88B0.00%1.88B0.00%1.88B-0.66%1.88B4.21%1.88B4.21%1.88B4.21%1.88B4.90%1.89B0.00%1.8B
Other equity instruments -0.00%214.75M-0.00%214.75M-0.00%214.75M-0.00%214.75M-0.00%214.75M-0.00%214.75M-0.00%214.75M-0.01%214.75M-10.73%214.75M-10.73%214.76M
Capital reserve funds 1.50%3.53B2.70%3.52B5.49%3.46B6.83%3.46B36.23%3.48B210.12%3.43B201.09%3.28B229.68%3.24B157.33%2.55B12.34%1.1B
Surplus reserve funds 10.31%732.54M10.31%732.54M10.31%732.54M10.32%732.54M13.48%664.05M13.48%664.05M13.48%664.05M13.48%664.04M45.37%585.17M45.37%585.17M
Retained profit -2.28%10.14B3.40%10.28B4.81%10.68B6.30%10.2B9.91%10.38B11.64%9.94B17.50%10.19B18.11%9.59B11.90%9.44B8.12%8.91B
Less:Treasury stock 71.01%608.49M56.24%555.92M42.14%505.77M21.15%431.06M-41.68%355.82M-40.68%355.82M-24.09%355.82M-2.30%355.82M139.93%610.1M135.89%599.84M
Other composite income -13.58%-92.23M-251.53%-181.25M-70.77%-83.67M10.88%-80.89M6.01%-81.2M52.95%-51.56M-6,951.87%-48.99M-170.41%-90.76M-169.84%-86.39M-155.54%-109.59M
Shareholders equity without minority interests -2.35%15.8B1.08%15.89B3.50%16.38B5.47%15.98B15.63%16.18B32.04%15.72B33.02%15.82B32.01%15.15B19.10%13.99B2.53%11.91B
Minority interests 5.68%1.5B18.64%1.55B29.66%1.63B24.24%1.52B57.29%1.42B43.28%1.31B54.99%1.26B53.14%1.22B18.31%904.77M27.19%911.57M
Total shareholder equity -1.70%17.3B2.43%17.44B5.43%18.01B6.88%17.5B18.16%17.6B32.84%17.03B34.43%17.08B33.39%16.37B19.05%14.9B3.97%12.82B
Total liabilityies and equity -0.01%25.01B3.51%25.3B3.86%25.51B2.19%25.02B6.12%25.01B12.54%24.44B14.81%24.56B18.29%24.48B13.60%23.57B1.19%21.72B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Gene Sequencing
Gene Sequencing
Intraday-0.13%
MSCI concept
MSCI concept
Intraday-0.21%
Transferring Securities of Securities
Transferring Securities of Securities
Intraday-0.31%